|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O'Connell MJ, Campbell ME, Goldberg RM,
Grothey A, Seitz JF, Benedetti JK, André T, Haller DG and Sargent
DJ: Survival following recurrence in stage II and III colon cancer:
Findings from the ACCENT data set. J Clin Oncol. 26:2336–2341.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hellstrom I, Horn D, Linsley P, Brown JP,
Brankovan V and Hellstrom KE: Monoclonal mouse antibodies raised
against human lung carcinoma. Cancer Res. 46:3917–3923.
1986.PubMed/NCBI
|
|
4
|
O'Donnell RT, DeNardo SJ, Shi XB, Mirick
GR, DeNardo GL, Kroger LA and Meyers FJ: L6 monoclonal antibody
binds prostate cancer. Prostate. 37:91–97. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wright MD, Ni J and Rudy GB: The L6
membrane proteins - a new four-transmembrane superfamily. Protein
Sci. 9:1594–1600. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang YW, Chen SC, Cheng EC, Ko YP, Lin
YC, Kao YR, Tsay YG, Yang PC, Wu CW and Roffler SR: CD13
(aminopeptidase N) can associate with tumor-associated antigen L6
and enhance the motility of human lung cancer cells. Int J Cancer.
116:243–252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lekishvili T, Fromm E, Mujoomdar M and
Berditchevski F: The tumour-associated antigen L6 (L6-Ag) is
recruited to the tetraspanin-enriched microdomains: Implication for
tumour cell motility. J Cell Sci. 121:685–694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kao YR, Shih JY, Wen WC, Ko YP, Chen BM,
Chan YL, Chu YW, Yang PC, Wu CW and Roffler SR: Tumor-associated
antigen L6 and the invasion of human lung cancer cells. Clin Cancer
Res. 9:2807–2816. 2003.PubMed/NCBI
|
|
9
|
Marken JS, Schieven GL, Hellström I,
Hellström KE and Aruffo A: Cloning and expression of the
tumor-associated antigen L6. Proc Natl Acad Sci USA. 89:3503–3507.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allioli N, Vincent S, Vlaeminck-Guillem V,
Decaussin-Petrucci M, Ragage F, Ruffion A and Samarut J: TM4SF1, a
novel primary androgen receptor target gene over-expressed in human
prostate cancer and involved in cell migration. Prostate.
71:1239–1250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Otsuka M, Kato M, Yoshikawa T, Chen H,
Brown EJ, Masuho Y, Omata M and Seki N: Differential expression of
the L-plastin gene in human colorectal cancer progression and
metastasis. Biochem Biophys Res Commun. 289:876–881. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ying SY, Chang DC, Miller JD and Lin SL:
The microRNA: Overview of the RNA gene that modulates gene
functions. Methods Mol Biol. 342:1–18. 2006.PubMed/NCBI
|
|
13
|
Wang F, Xue X, Wei J, An Y, Yao J, Cai H,
Wu J, Dai C, Qian Z, Xu Z, et al: hsa-miR-520h downregulates ABCG2
in pancreatic cancer cells to inhibit migration, invasion, and side
populations. Br J Cancer. 103:567–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou L, Liu F, Wang X and Ouyang G: The
roles of microRNAs in the regulation of tumor metastasis. Cell
Biosci. 5:322015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aguda BD, Kim Y, Piper-Hunter MG, Friedman
A and Marsh CB: MicroRNA regulation of a cancer network:
Consequences of the feedback loops involving miR-17–92, E2F, and
Myc. Proc Natl Acad Sci USA. 105:19678–19683. 2008. View Article : Google Scholar
|
|
16
|
Grady WM, Parkin RK, Mitchell PS, Lee JH,
Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz
AM, et al: Epigenetic silencing of the intronic microRNA
hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene.
27:3880–3888. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mo JS, Alam KJ, Kang IH, Park WC, Seo GS,
Choi SC, Kim HS, Moon HB, Yun KJ and Chae SC: MicroRNA 196B
regulates FAS-mediated apoptosis in colorectal cancer cells.
Oncotarget. 6:2843–2855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hoffman AE, Zheng T, Yi C, Leaderer D,
Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA
miR-196a-2 and breast cancer: A genetic and epigenetic association
study and functional analysis. Cancer Res. 69:5970–5977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aqeilan RI, Calin GA and Croce CM: miR-15a
and miR-16-1 in cancer: Discovery, function and future
perspectives. Cell Death Differ. 17:215–220. 2010. View Article : Google Scholar
|
|
20
|
Zhang J, Jia J, Zhao L, Li X, Xie Q, Chen
X, Wang J and Lu F: Down-regulation of microRNA-9 leads to
activation of IL-6/Jak/STAT3 pathway through directly targeting
IL-6 in HeLa cell. Mol Carcinog. Mar 25–2015.n/a, 2015. View Article : Google Scholar : Epub ahead of
print.
|
|
21
|
Mohammadi-Yeganeh S, Mansouri A and Paryan
M: Targeting of miR9/NOTCH1 interaction reduces metastatic behavior
in triple-negative breast cancer. Chem Biol Drug Des. 86:1185–1191.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Laios A, O'Toole S, Flavin R, Martin C,
Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, et al:
Potential role of miR-9 and miR-223 in recurrent ovarian cancer.
Mol Cancer. 7:352008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Higashi T, Hayashi H, Ishimoto T, Takeyama
H, Kaida T, Arima K, Taki K, Sakamoto K, Kuroki H, Okabe H, et al:
miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in
hepatocellular carcinoma cells. Br J Cancer. 113:252–258. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo H, Zhang H, Zhang Z, Zhang X, Ning B,
Guo J, Nie N, Liu B and Wu X: Down-regulated miR-9 and miR-433 in
human gastric carcinoma. J Exp Clin Cancer Res. 28:822009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tagawa T, Haraguchi T, Hiramatsu H,
Kobayashi K, Sakurai K, Inada K and Iba H: Multiple microRNAs
induced by Cdx1 suppress Cdx2 in human colorectal tumour cells.
Biochem J. 447:449–455. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu M, Xu Y, Ge M, Gui Z and Yan F:
Regulation of UHRF1 by microRNA-9 modulates colorectal cancer cell
proliferation and apoptosis. Cancer Sci. 106:833–839. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sarver AL, French AJ, Borralho PM,
Thayanithy V, Oberg AL, Silverstein KA, Morlan BW, Riska SM,
Boardman LA, Cunningham JM, et al: Human colon cancer profiles show
differential microRNA expression depending on mismatch repair
status and are characteristic of undifferentiated proliferative
states. BMC Cancer. 9:4012009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Slattery ML, Herrick JS, Mullany LE,
Valeri N, Stevens J, Caan BJ, et al: An evaluation and replication
of miRNAs with disease stage and colorectal cancer-specific
mortality. Int J Cancer. 137:428–438. 2015. View Article : Google Scholar
|
|
29
|
Bandres E, Agirre X, Bitarte N, Ramirez N,
Zarate R, Roman-Gomez J, Prosper F and Garcia-Foncillas J:
Epigenetic regulation of microRNA expression in colorectal cancer.
Int J Cancer. 125:2737–2743. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo
T and Yuasa Y: MiR-9 downregulates CDX2 expression in gastric
cancer cells. Int J Cancer. 129:2611–2620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim SL, Liu YC, Park YR, Seo SY, Kim SH,
Kim IH, Lee SO, Lee ST, Kim DG and Kim SW: Parthenolide enhances
sensitivity of colorectal cancer cells to TRAIL by inducing death
receptor 5 and promotes TRAIL-induced apoptosis. Int J Oncol.
46:1121–1130. 2015.
|
|
32
|
Liu LP, Liang HF, Chen XP, Zhang WG, Yang
SL, Xu T and Ren L: The role of NF-kappaB in Hepatitis b virus X
protein-mediated upregulation of VEGF and MMPs. Cancer Invest.
28:443–451. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim Y, Kang H, Jang SW and Ko J: Celastrol
inhibits breast cancer cell invasion via suppression of
NF-κB-mediated matrix metalloproteinase-9 expression. Cell Physiol
Biochem. 28:175–184. 2011. View Article : Google Scholar
|
|
34
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Duffy MJ, Maguire TM, Hill A, McDermott E
and O'Higgins N: Metalloproteinases: Role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
View Article : Google Scholar
|
|
37
|
Hanemaaijer R, Verheijen JH, Maguire TM,
Visser H, Toet K, McDermott E, O'Higgins N and Duffy MJ: Increased
gelatinase-A and gelatinase-B activities in malignant vs. benign
breast tumors. Int J Cancer. 86:204–207. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mc Donnell S, Chaudhry V, Mansilla-Soto J,
Zeng ZS, Shu WP and Guillem JG: Metastatic and non-metastatic
colorectal cancer (CRC) cells induce host metalloproteinase
production in vivo. Clin Exp Metastasis. 17:341–349. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shih SC, Zukauskas A, Li D, Liu G, Ang LH,
Nagy JA, Brown LF and Dvorak HF: The L6 protein TM4SF1 is critical
for endothelial cell function and tumor angiogenesis. Cancer Res.
69:3272–3277. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nass D, Rosenwald S, Meiri E, Gilad S,
Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A,
Kharenko O, et al: MiR-92b and miR-9/9* are specifically expressed
in brain primary tumors and can be used to differentiate primary
from metastatic brain tumors. Brain Pathol. 19:375–383. 2009.
View Article : Google Scholar :
|
|
42
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
43
|
Shiiyama R, Fukushima S, Jinnin M,
Yamashita J, Miyashita A, Nakahara S, Kogi A, Aoi J, Masuguchi S,
Inoue Y, et al: Sensitive detection of melanoma metastasis using
circulating microRNA expression profiles. Melanoma Res. 23:366–372.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Song Y, Li J, Zhu Y, Dai Y, Zeng T, Liu L,
Li J, Wang H, Qin Y, Zeng M, et al: MicroRNA-9 promotes tumor
metastasis via repressing E-cadherin in esophageal squamous cell
carcinoma. Oncotarget. 5:11669–11680. 2014. View Article : Google Scholar : PubMed/NCBI
|
